Journal article

Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E

SM Laws, E Hone, K Taddei, C Harper, B Dean, C McClean, C Masters, N Lautenschlager, SE Gandy, RN Martins

Molecular Psychiatry | NATURE PUBLISHING GROUP | Published : 2002

Abstract

The apolipoprotein E (APOE, gene; apoE, protein) type 4 isoform is a well-established risk factor for late-onset Alzheimer's disease (AD), and new data suggest that APOE promoter polymorphisms might also modulate AD risk, perhaps by altering transcription of the APOE gene. The current study was undertaken to determine whether the presence of the APOE promoter -491AA genotype (that appears to increase the risk for AD) is associated with an increase in the levels of apoE in brain tissue. Among 40 control and 20 autopsy-confirmed AD brain samples, levels of apoE were increased in the frontal cortex of AD cases (P < 0.001), consistent with the well-recognized up-regulation of APOE expression in ..

View full abstract